{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:34:22Z","timestamp":1789173262446,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"NRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.vph.2025.107466","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:08:06Z","timestamp":1738973286000},"page":"107466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effects of FGF-related gene polymorphisms on cerebral infarction in patients treated with direct oral anticoagulants"],"prefix":"10.1016","volume":"158","author":[{"given":"Jung Sun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minju","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-A","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo-A","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jeong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hyeok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Jin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbeom","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sun","family":"Gwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2025.107466_bb0005","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/jth.13323","article-title":"Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH","volume":"14","author":"Martin","year":"2016","journal-title":"J. Thrombos. Haemostasis: JTH"},{"key":"10.1016\/j.vph.2025.107466_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/STROKEAHA.110.584086","article-title":"Prevalence of coronary atherosclerosis in patients with cerebral infarction","volume":"42","author":"Amarenco","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2025.107466_bb0015","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.STR.29.5.913","article-title":"Cigarette smoking and other risk factors for silent cerebral infarction in the general population","volume":"29","author":"Howard","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2025.107466_bb0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/14034940600731523","article-title":"Risk-factor profile for the incidence of subarachnoid and intracerebral haemorrhage, cerebral infarction, and unspecified stroke during 21 years\u2019 follow-up in men","volume":"34","author":"H\u00e5heim","year":"2006","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.vph.2025.107466_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1407183","article-title":"Apolipoprotein E \u03b54 polymorphism as a risk factor for ischemic stroke: a systematic review and meta-analysis","volume":"2022","author":"Qiao","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.vph.2025.107466_bb0030","first-page":"CR208-212","article-title":"Paraoxonase1 polymorphism Leu-Met55 is associated with cerebral infarction in Japanese population","volume":"9","author":"Ueno","year":"2003","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.vph.2025.107466_bb0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1017\/S0317167100006259","article-title":"Meta-analysis of the ACE gene polymorphism in cerebral infarction","volume":"36","author":"Tao","year":"2009","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.vph.2025.107466_bb0040","first-page":"98","article-title":"The association between vascular endothelial growth factor gene polymorphisms and stroke: A PRISMA-compliant meta-analysis","author":"Xu","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.vph.2025.107466_bb0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000501145","article-title":"Fibroblast growth factors: a controlling mechanism of skin aging","volume":"4","author":"de Ara\u00fajo","year":"2019","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.vph.2025.107466_bb0050","first-page":"10","article-title":"Cellular mechanisms of FGF-stimulated tissue repair","volume":"2021","author":"Prudovsky","year":"1830","journal-title":"Cells"},{"key":"10.1016\/j.vph.2025.107466_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.31491\/APT.2021.09.065","article-title":"Progress on the study of fibroblast growth factors as novel therapeutics in post-stroke cognitive impairment","volume":"3","author":"Li","year":"2021","journal-title":"Aging Pathobiol. Therap."},{"key":"10.1016\/j.vph.2025.107466_bb0060","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41401-023-01061-2","article-title":"Angiogenesis after ischemic stroke","volume":"44","author":"Fang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.vph.2025.107466_bb0065","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1161\/STROKEAHA.111.642710","article-title":"Angiogenesis: a harmonized target for recovery after stroke","volume":"43","author":"Ergul","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2025.107466_bb0070","article-title":"Cardiovascular toxicity associated with angiogenesis inhibitors: a comprehensive pharmacovigilance analysis based on the FDA adverse event reporting system database from 2014 to 2021","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.vph.2025.107466_bb0075","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.2008.656","article-title":"Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis","volume":"300","author":"Nalluri","year":"2008","journal-title":"Jama"},{"key":"10.1016\/j.vph.2025.107466_bb0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.beha.2009.01.001","article-title":"Thrombosis associated with angiogenesis inhibitors","volume":"22","author":"Elice","year":"2009","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.vph.2025.107466_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.671131","article-title":"Roles of fibroblast growth factors and their therapeutic potential in treatment of ischemic stroke","volume":"12","author":"Dordoe","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.vph.2025.107466_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cytogfr.2020.05.004","article-title":"Intracellular partners of fibroblast growth factors 1 and 2-implications for functions","volume":"57","author":"Sluzalska","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.vph.2025.107466_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170645","article-title":"Contribution of FGFR1 variants to craniofacial variations in east Asians","volume":"12","author":"Adel","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2025.107466_bb0100","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/jnr.21087","article-title":"Modeling the neurovascular niche: VEGF-and BDNF-mediated cross-talk between neural stem cells and endothelial cells: an in vitro study","volume":"84","author":"Li","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.vph.2025.107466_bb0105","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00004647-200110000-00011","article-title":"Angiogenesis after stroke is correlated with increased numbers of macrophages: the clean-up hypothesis","volume":"21","author":"Manoonkitiwongsa","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.vph.2025.107466_bb0110","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.WCB.0000126236.54306.21","article-title":"Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis","volume":"24","author":"Manoonkitiwongsa","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.vph.2025.107466_bb0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.vph.2025.107466_bb0120","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10549-013-2644-5","article-title":"Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the breast Cancer health disparities study","volume":"140","author":"Slattery","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.vph.2025.107466_bb0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/JTO.0b013e318274a85d","article-title":"A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non\u2013small-cell lung cancer: north central Cancer treatment group study N0528","volume":"8","author":"Dy","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.vph.2025.107466_bb0130","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ajmg.a.31620","article-title":"Interferon regulatory factor 6 (IRF6) and fibroblast growth factor receptor 1 (FGFR1) contribute to human tooth agenesis","volume":"143a","author":"Vieira","year":"2007","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.vph.2025.107466_bb0135","series-title":"Determination of Genomic Variants of the Complex Aetiology Cleft Lip and (or) Palate in Lithuanian Patient Group","author":"Ambrozaityt\u0117","year":"2011"},{"key":"10.1016\/j.vph.2025.107466_bb0140","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1093\/nar\/gkab1112","article-title":"Database resources of the national center for biotechnology information","volume":"50","author":"Sayers","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.vph.2025.107466_bb0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/dj4010005","article-title":"New direct oral anticoagulants (DOAC) and their use today","volume":"4","author":"Schwarb","year":"2016","journal-title":"Dent. J."},{"key":"10.1016\/j.vph.2025.107466_bb0150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.yjmcc.2018.09.003","article-title":"Factor Xa inhibition by rivaroxaban regulates fibrogenesis in human atrial fibroblasts with modulation of nitric oxide synthesis and calcium homeostasis","volume":"123","author":"Chung","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.vph.2025.107466_bb0155","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00702-009-0329-3","article-title":"Growth factors improve neurogenesis and outcome after focal cerebral ischemia","volume":"116","author":"Leker","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.vph.2025.107466_bb0160","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/1078-0432.CCR-11-0659","article-title":"Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis","volume":"17","author":"Lieu","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.vph.2025.107466_bb0165","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1161\/01.CIR.0000128595.79378.FA","article-title":"Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines","volume":"109","author":"Losordo","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107466_bb0170","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/01.CIR.0000159345.00591.8F","article-title":"Angiogenesis: where do we stand now?","volume":"111","author":"Simons","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107466_bb0175","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-0043-104532","article-title":"Serum fibroblast growth factor 1 is associated with the decreased risk of obesity in human","volume":"125","author":"Zhu","year":"2017","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.vph.2025.107466_bb0180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1507\/endocrj.EJ15-0627","article-title":"Fibroblast growth factor 1 levels are elevated in newly diagnosed type 2 diabetes compared to normal glucose tolerance controls","volume":"63","author":"Wang","year":"2016","journal-title":"Endocr. J."},{"key":"10.1016\/j.vph.2025.107466_bb0185","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.humpath.2015.07.022","article-title":"Clinicopathological significance of fibroblast growth factor 1 in non-small cell lung cancer","volume":"46","author":"Li","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.vph.2025.107466_bb0190","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s12015-017-9755-z","article-title":"Fibroblast growth factor type 1 (FGF1)-overexpressed adipose-derived Mesenchaymal stem cells (AD-MSC(FGF1)) induce neuroprotection and functional recovery in a rat stroke model","volume":"13","author":"Ghazavi","year":"2017","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.vph.2025.107466_bb0195","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrg1327","article-title":"Genomic variants in exons and introns: identifying the splicing spoilers","volume":"5","author":"Pagani","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.vph.2025.107466_bb0200","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues","volume":"550","author":"Mohammadi Pejman 5 6 Park YoSon 11 Parsana Princy 12 Segr\u00e8 Ayellet V. 1 Strober Benjamin J. 9 Zappala Zachary 7 8, G.C.L.a.A.F.B.A.A.C.S.E.D.J.R.H.Y.J.B.; P. 19 Volpi Simona 19, N.p.m.A.A.G.P.K.S.L.A.R.L.N.C.M.H.M.R.A.S.J.; 16, P.S.L.B.M.E.B.P.A.; 137, N.C.F.N.C.R","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.vph.2025.107466_bb0205","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1161\/CIRCULATIONAHA.107.710293","article-title":"Fibroblast growth factor 1 gene and hypertension: from the quantitative trait locus to positional analysis","volume":"116","author":"Tomaszewski","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107466_bb0210","doi-asserted-by":"crossref","first-page":"13379","DOI":"10.1073\/pnas.1324235111","article-title":"Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis","volume":"111","author":"Oladipupo","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.vph.2025.107466_bb0215","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.3390\/cancers13122968","article-title":"FGFR inhibitors in oncology: insight on the management of toxicities in clinical practice","volume":"13","author":"Kommalapati","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.vph.2025.107466_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6606-2-16","article-title":"Molecular genetic analysis of FGFR1 signalling reveals distinct roles of MAPK and PLC\u03b31 activation for self-renewal of adult neural stem cells","volume":"2","author":"Ma","year":"2009","journal-title":"Mol. Brain"},{"key":"10.1016\/j.vph.2025.107466_bb0225","doi-asserted-by":"crossref","first-page":"E962","DOI":"10.1210\/jc.2010-2639","article-title":"Genetic association and gene expression analysis identify FGFR1 as a new susceptibility gene for human obesity","volume":"96","author":"Jiao","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.vph.2025.107466_bb0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/EJE-08-0021","article-title":"Single nucleotide polymorphisms in new candidate genes are associated with bone mineral density and fracture risk","volume":"159","author":"Laz\u00e1ry","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.vph.2025.107466_bb0235","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1212\/01.wnl.0000267275.68538.8d","article-title":"Independent predictors of stroke in patients with atrial fibrillation: a systematic review","volume":"69","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.vph.2025.107466_bb0240","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.18632\/aging.101931","article-title":"Aging and ischemic stroke","volume":"11","author":"Yousufuddin","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.vph.2025.107466_bb0245","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH07-08-0508","article-title":"Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data","volume":"99","author":"Hughes","year":"2008","journal-title":"Thromb. Haemost."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T10:14:53Z","timestamp":1741256093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189125000059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":49,"alternative-id":["S1537189125000059"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2025.107466","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of FGF-related gene polymorphisms on cerebral infarction in patients treated with direct oral anticoagulants","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2025.107466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107466"}}